Alector, Inc. (ALEC) stock
ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3069% below fair value
$2.54+0.09 (+3.67%)
Close on Nov 13, 2026Market cap $283.61MP/E 7.3Yield –
Alector profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Alector's profit margin for the twelve months ending Sep 30, 2026 was 23.9%. For fiscal 2025 it was -679.2%, against -118.4% the year before. The highest annual figure on record is -17.5% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -679.2% | −560.8 |
| FY2024 | Dec 31, 2024 | -118.4% | +15.9 |
| FY2023 | Dec 31, 2023 | -134.3% | −34.5 |
| FY2022 | Dec 31, 2022 | -99.8% | −82.2 |
| FY2021 | Dec 31, 2021 | -17.5% | +884.1 |
| FY2020 | Dec 31, 2020 | -901.6% | −405.0 |
| FY2019 | Dec 31, 2019 | -496.7% | −307.9 |
| FY2018 | Dec 31, 2018 | -188.8% | +680.8 |
| FY2017 | Dec 31, 2017 | -869.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 76.5% | +1139.9 |
| Q2 FY2026 | Jun 30, 2026 | -692.5% | −304.8 |
| Q1 FY2026 | Mar 31, 2026 | -2192.2% | −1090.6 |
| Q4 FY2025 | Dec 31, 2025 | -597.5% | −593.7 |
| Q3 FY2025 | Sep 30, 2025 | -1063.4% | −788.2 |
| Q2 FY2025 | Jun 30, 2025 | -387.7% | −131.2 |
| Q1 FY2025 | Mar 31, 2025 | -1101.6% | −874.6 |
| Q4 FY2024 | Dec 31, 2024 | -3.8% | +268.3 |
| Q3 FY2024 | Sep 30, 2024 | -275.2% | +213.1 |
| Q2 FY2024 | Jun 30, 2024 | -256.4% | −258.9 |
| Q1 FY2024 | Mar 31, 2024 | -226.9% | +50.2 |
| Q4 FY2023 | Dec 31, 2023 | -272.1% | +91.4 |
| Q3 FY2023 | Sep 30, 2023 | -488.3% | −177.5 |
| Q2 FY2023 | Jun 30, 2023 | 2.4% | −9.9 |
| Q1 FY2023 | Mar 31, 2023 | -277.1% | −94.8 |
| Q4 FY2022 | Dec 31, 2022 | -363.5% | +33.9 |
| Q3 FY2022 | Sep 30, 2022 | -310.7% | −380.1 |
| Q2 FY2022 | Jun 30, 2022 | 12.4% | +852.0 |
| Q1 FY2022 | Mar 31, 2022 | -182.3% | +1087.1 |
| Q4 FY2021 | Dec 31, 2021 | -397.4% | +677.8 |
| Q3 FY2021 | Sep 30, 2021 | 69.4% | +962.1 |
| Q2 FY2021 | Jun 30, 2021 | -839.6% | +590.2 |
| Q1 FY2021 | Mar 31, 2021 | -1269.4% | −711.3 |
| Q4 FY2020 | Dec 31, 2020 | -1075.2% | −566.5 |
| Q3 FY2020 | Sep 30, 2020 | -892.7% | +284.5 |
| Q2 FY2020 | Jun 30, 2020 | -1429.8% | −1074.8 |
| Q1 FY2020 | Mar 31, 2020 | -558.1% | −226.9 |
| Q4 FY2019 | Dec 31, 2019 | -508.7% | −318.7 |
| Q3 FY2019 | Sep 30, 2019 | -1177.2% | −941.7 |
| Q2 FY2019 | Jun 30, 2019 | -355.1% | −198.6 |
| Q1 FY2019 | Mar 31, 2019 | -331.1% | −159.6 |
| Q4 FY2018 | Dec 31, 2018 | -190.0% | – |
| Q3 FY2018 | Sep 30, 2018 | -235.5% | – |
| Q2 FY2018 | Jun 30, 2018 | -156.4% | – |
| Q1 FY2018 | Mar 31, 2018 | -171.5% | – |
See a number that looks wrong?